l9n/ Mississippi

2017 Regular Session

House Bill 1031

Drug Schedules I, II and III; revise.

Did not become law. It stopped in the Senate's Drug Policy Committee on February 28, 2017. The 2017 session has ended.

What it does

The synopsis the Legislature published with the bill.

AN ACT TO AMEND SECTION 41-29-113, MISSISSIPPI CODE OF 1972, TO REVISE SCHEDULE I TO INCLUDE AH-7921, BUTYRYL FENTANYL AND BETA-HYDROXYTHIOFENTANYL; TO AMEND SECTIONS 41-29-115 AND 41-29-117, MISSISSIPPI CODE OF 1972, TO EXCLUDE PENTAZOCINE, A SCHEDULE IV DRUG, FROM LISTING ON SCHEDULES II AND III; TO AMEND SECTION 41-29-119, MISSISSIPPI CODE OF 1972, TO REVISE SCHEDULE IV TO INCLUDE ELUXADOLINE; TO AMEND SECTION 41-29-121, MISSISSIPPI CODE OF 1972, TO REVISE SCHEDULE V TO INCLUDE BRIVARACETAM; AND FOR RELATED PURPOSES.

Sponsors

Who carried the bill in each chamber, and who signed on. Each name leads to the member's page.

In the House of Representatives

1 co-sponsor

Deborah Butler Dixon

Its course

January 16 to February 28, 2017, on one scale. In the top row each mark is a day something happened; taller marks are busier days.

Each committee stop sits inside its chamber.

Every action6 actions on 6 days

In the House of RepresentativesJan 16 to Feb 722 days

Drug PolicyJan 16 to Jan 259 days

In the SenateFeb 7 to Feb 28 · stopped21 days

Drug PolicyFeb 15 to Feb 28 · stopped13 days

Text

Each version as the Legislature printed it.

l9n doesn't hold this bill's text yet.

What happened

In l9n's words, one line for each step. Every action as the Legislature published it is below.

In the House of Representatives Jan 16 – Feb 7

  1. Referred to the House committee on Drug Policy
  2. Reported from committee in the House: title sufficient, do pass
  3. Passed the House

In the Senate Feb 8 – Feb 28

  1. Sent to the Senate
  2. Referred to the Senate committee on Drug Policy
  3. Died in committee in the Senate
All 6 actions, as published